SLS-005 Given Orphan Drug Designation for Sanfilippo in EU

The European Medicines Agency has granted orphan drug designation to SLS-005 (trehalose) for the treatment of Sanfilippo syndrome. This designation, which follows a positive opinion from the agency’s Committee for Orphan Medicinal Products, was announced in a press release from Seelos…